CXCR3 blockade: a novel anti-sepsis approach?

Blockade of the CXC chemokine receptor 3 (CXCR3) attenuates inflammation and improves survival in a murine model of near lethal polymicrobial sepsis. However, given the multitude of cellular responses and inflammatory mediators that orchestrate sepsis syndrome, more detailed investigations will be r...

Descripción completa

Detalles Bibliográficos
Autores principales: Delano, Matthew J, Moldawer, Lyle L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672571/
https://www.ncbi.nlm.nih.gov/pubmed/23171733
http://dx.doi.org/10.1186/cc11818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672571/
https://www.ncbi.nlm.nih.gov/pubmed/23171733
http://dx.doi.org/10.1186/cc11818

Ejemplares similares